Yoon Sung Ho, Kim Seong Keun, Kim Jihyun F
Industrial Biotechnology and Bioenergy Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Yuseong, Daejeon, Republic of Korea.
Recent Pat Biotechnol. 2010 Jan;4(1):23-9. doi: 10.2174/187220810790069550.
Extracellular production of heterologous proteins using the Escherichia coli cell factory offers several advantages over intracellular production and mammalian culture. Properly folded proteins can be rapidly accumulated in the culture media, and downstream processes for isolation and purification can be much simplified. Efforts to enhance the secretory production of target proteins can be largely classified as selection and modification of the signal peptide, co-expression of proteins to assist translocation and folding, improvement of periplasmic release, and protection of target proteins from degradation and contamination. Here, we review recent patents on the secretory production of recombinant proteins in E. coli.
利用大肠杆菌细胞工厂进行异源蛋白的胞外生产比胞内生产和哺乳动物细胞培养具有若干优势。正确折叠的蛋白质能够在培养基中快速积累,并且分离和纯化的下游工艺可大大简化。增强目标蛋白分泌生产的努力在很大程度上可分为信号肽的选择和修饰、共表达有助于转运和折叠的蛋白质、改善周质释放以及保护目标蛋白不被降解和污染。在此,我们综述了近期关于大肠杆菌中重组蛋白分泌生产的专利。